Overview
The Coalition for Epidemic Preparedness Innovations (CEPI) is supporting different vaccine candidates targeting the SARS-CoV-2 virus (Severe acute respiratory syndrome coronavirus 2). Comparing immune responses against different vaccine candidates intended for the prevention of SARS-CoV-2 is challenging. In order to reduce some of this complexity, better assess the immunological profile of each vaccine candidate, and provide robust assays for regulatory purposes, CEPI created a Centralized Laboratory Network to test the immune response elicited by different vaccine in preclinical studies and Phase I and IIa clinical studies.

For more info: https://cepi.net/news_cepi/cepi-establishes-global-network-of-laboratories-to-centralise-assessment-of-covid-19-vaccine-candidates/

Sample Analysis Request form
Please, fill ONE Sample Analysis Request form for each phase of development (pre-clinical, Ph I, Ph II) in order to apply for analysis. Prioritize the 3 most relevant timepoints and samples from your most advanced stage of development. 

A member of our team will will contact you shortly!

Please note incomplete applications will not be considered.

For more info: centralizedlab@cepi.net

Question Title

* 1. Vaccine Developer name:

Question Title

* 2. Point of contact details (name and email address):

Question Title

* 3. Current phase of vaccine development:

Question Title

* 4. Type of samples to be sent for testing:

Question Title

* 5. Study phase of the samples:

Question Title

* 6. Number of samples: (If samples are from more than one specie, specify number of samples per specie)

Question Title

* 7. Samples location:

Question Title

* 8. Anticipated date of shipment:

Question Title

* 9. Type of analysis requested:

Question Title

* 10. Are you already working with any Lab for immunogenicity sample measurement for the above mentioned assays? 

Question Title

* 11. Are you currently funded by CEPI?

T